Expert overview (PDF)
Dr Stuart Goldberg
Hackensack University Medical , USA

 

Abstract 4058 (PDF)

A Taher

Deferasirox (Exjade®) ≥30 mg/kg/day is Effective in Reducing Iron Burden in Thalassemia Major Patients Previously Chelated with Monotherapy or Combination Therapy

 

Abstract 4063 (PDF)

MD Cappellini

Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to
5 Years

Abstract 4062 (PDF)

DJ Pennell

Efficacy and Safety of Deferasirox (Exjade®) in β-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study

Abstract 4069 (PDF)

John C. Wood
Initial Liver Iron Predicts Cardiac Chelation Efficacy of Deferasirox (Exjade®) Monotherapy in Chronically Transfused β-Thalassemia (β-Thal) Patients: 18- and 24-Month Data

Abstract 2013 (PDF)

Antonios Kattamis

Prevalence of Cardiac Dysfunction in Patients with Thalassemia Major with Respect to Cardiac Magnetic Resonance

Abstract 1768 (PDF)

M Schmid

Safety of Deferasirox (Exjade®) in Myelodysplastic Syndromes (MDS) and Non-MDS Patients with Transfusional Iron Overload: A Pooled Analysis
Focusing On Renal Function

Abstract 3829 (PDF)

Alan F List

Two-Year Analysis of Efficacy and Safety of Deferasirox (Exjade®) Treatment in Myelodysplastic Syndrome Patients Enrolled in the US03 Study

Abstract 3806 (PDF)

Mathias Schmid

Deferasirox (Exjade®) Is Effective and Well Tolerated in Chelation-Naive and Previously Chelated Patients with Transfusion-Dependent Myelodysplastic Syndromes (MDS)

 

Abstract 3803 (PDF)

N Gattermann,

Correlation Between Decreased Serum Ferritin and Improved Liver Transaminases During Deferasirox (Exjade®) Treatment in Iron-Overloaded Patients with Myelodysplastic Syndromes

Abstract 1747 (PDF)

Frank Fox

Matched-Pair Analysis of 186 MDS Patients Receiving Iron Chelation Therapy or Transfusion Therapy Only

 

Abstract 3805 (PDF)

Gattermann N

Deferasirox (Exjade®) Treatment of Chelation-Naive and Pre-Chelated MDS Patients with Transfusional Iron-Overload in the Medical Practice: Results From the Observational Studies Extend and Exjange

Abstract 2005 (PDF)

Maciej W Garbowski

Vitamin C Status in Transfusionally Iron-Overloaded Patients On Long-Term Deferasirox and Its Relationship to Myocardial Iron Removal

 

掲載されている薬剤の使用に当たっては添付文書をご参照ください